|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/444 | |
| A61K 31/506 | |||
| A61K 45/06 | |||
| A61P 37/00 | |||
| C07D 401/04 | |||
| C07D 403/04 | |||
| C07D 409/04 | |||
| C07D 413/14 |
| (11) | Number of the document | 3200787 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15846218.4 |
| Date of filing the European patent application | 2015-09-25 | |
| (97) | Date of publication of the European application | 2017-08-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/052111 |
| Date | 2015-09-25 |
| (87) | Number | WO 2016/053771 |
| Date | 2016-04-07 |
| (30) | Number | Date | Country code |
| 201462057692 P | 2014-09-30 | US |
| (72) |
ALTMAN, Michael D., US
ANDRESEN, Brian M., US
BRUBAKER, Jason D., US
CHILDERS, Matthew L., US
DONOFRIO, Anthony, US
FISCHMANN, Thierry, US
GIBEAU, Craig R., US
KATTAR, Solomon D., US
LESBURG, Charles A., US
LIM, Jongwon, US
MACLEAN, John K. F., GB
MANSOOR, Umar F., US
NORTHRUP, Alan B., US
SANDERS, John M., US
SMITH, Graham F., US
TORRES, Luis, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | INHIBITORS OF IRAK4 ACTIVITY |
| INHIBITORS OF IRAK4 ACTIVITY |